A new ammonium acetate-assisted, convenient and efficient procedure for the synthesis of arylidene derivatives of thiazolopyrimidine is described. The main advantages of this protocol is that it is economical, short reaction time, commonly available chemicals, and ease of isolation of products. In addition, a new series of thiazole-fused pyrimidines were synthesized and hydrolysis of one of its arylidene derivative studied. All the compounds were characterized by analytical and spectroscopic methods. Further, the structure of hydrolyzed product and two other compounds were confirmed by X-ray crystal structure analysis. The crystal structures are stabilized by intermolecular C-H. . .O, C-H. . .N, C-H. . . π and π . . . π weak interactions. The anti-microbial screening was done on the compounds in order to test their anti-bacterial and anti-fungal activities.
Introduction
Heterocycles containing sulphur and nitrogen are of great interest because they constitute an important class of natural and synthetic organic molecules, many of which exhibit useful biological activity. One such heterocyclic class is thiazolopyrimidines. These have generated interest in recent years due to their biological and pharmaceutical activities. These ring systems have shown anti-microbial, [1] [2] [3] [4] anti-malarial, 5 anti-inflammatory, 6, 7 anti-oxidant, 6 anti-nociceptive 7 and antitubercular 8 activity. In addition, they have been reported to possess anti-tumour activity 9, 10 and have also shown to possess anti-parkinsonian and anti-proliferative properties. 11 In view of all these observations, we have undertaken the synthesis of some new derivatives of thiazolo [3,2-a] pyrimidines. The traditional methods 7, [12] [13] [14] to synthesize arylidene derivative involve the use of 1:1 mixture of acetic acid and acetic anhydride in presence of sodium acetate. But this method is not satisfactory with regard to the isolation of the products and also due to the drastic reaction conditions that are employed. To overcome this limitation, we have developed a new protocol for the synthesis of arylidene derivative of thiazolopyrimidines using readily available, inexpensive and environment-friendly catalysts. We have made * For correspondence use of ammonium acetate under warm condition with ethanol as a solvent medium. It is a convenient and fast protocol, although the synthetic route followed is a conventional one. However, the duration of the reaction is very short, as it goes to completion in 10 min. This is yet another advantage of the present protocol.
In continuation of our work with thiazolopyrimidines, we report herein the synthesis of some new derivatives and a tricyclic thiazolopyrimidine. It has been observed that the hydrolysis of arylidene derivative of thiazolopyrimidine occurs via rupture of imine bond under acidic condition. In this paper, the mechanism for hydrolysis has been proposed. Some of these derivatives exhibit promising anti-microbial activities. We have presented here the crystal structure analysis of the two derivatives. The structure analysis was undertaken to determine the configuration and conformation of the molecule and the orientation of the substituents around the thiazolopyrimidine framework.
Experimental

Materials and methods
All the chemicals were purchased from S D Fine and Spectrochem used as received without further purification. Melting point apparatus was used to determine the melting point in open capillaries and are uncorrected. IR spectra were recorded on Nicolet Impact 400D FT-IR 468 H Nagarajaiah et al. spectrophotometer using KBr pellets. Bruker 400 MHz FT-NMR spectrometer was used to record 1 H and 13 C NMR in CDCl 3 and DMSO-d 6 with TMS as internal standard. The reactions and purity of the products were monitored by TLC silica gel plates. Mass spectra were recorded on LC-MSD-Trap-SL spectrometer and elemental analyses were carried out using CHNS Elimentar (Vario-micro cube).
Procedure for the synthesis of compounds 2(a-d)
A mixture of ethyl 3,5-dihydro-7-methyl-3-oxo-5-phenyl-2H -thiazolo[3,2−a]pyrimidine-6-carboxylate (1a/1d/1e) (10 mmol), aromatic aldehydes (10 mmol) and catalytic amount of ammonium acetate in ethanol (30 mL) was warmed for 5-10 min with constant stirring. The reaction mixture was allowed to stand at room temperature for 30 min. The solid thus separated was filtered and washed with water and recrystsallized from ethanol to afford yellow compound with good yield 82-87%. [3,2-a] (3.76) , N 9.74 (9.63), S 7.43 (7.59). [3,2-a] 2.3a Method 1: Compound 1a was refluxed with benzaldehyde in presence of ammonium acetate in acetic acid for 5-6 h with constant stirring. The reaction mixture was allowed to stand at room temperature overnight. The solid thus separated was filtered, washed with water and recrystallized from ethanol to afford pale yellow crystals in good yield (82%).
2.2a (2Z)-Ethyl 2-benzylidene-3,5-dihydro-7-methyl-3-oxo-5-phenyl-2H-thiazolo
2.2c 4-((1Z)-(6-(ethoxycarbonyl)-5-(4-hydroxyphenyl)-7 -methyl-3-oxo-3H-thiazolo
2.3b Method 2:
A mixture of compound 2a and catalytic amount of conc. HCl in ethanol (100 mL) was refluxed for 5-6 h with constant stirring. The reaction mixture was allowed to stand room temperature overnight. The solid thus separated was filtered, washed with water and recrystsallized from ethanol to afford good quality crystals (yield 80%). A mixture of ethyl 3,5-dihydro-7-methyl-3-oxo-5-substituted phenyl-2H -thiazolo[3,2−a]pyrimidine-6-carboxylate (5 mmol), morpholine (6 mmol), formalin (1 mL) and acetic acid (1 mL) in methanol (20 mL) was refluxed for 8 h (monitored by TLC). Reaction mixture was diluted with water and extracted with chloroform (3 × 30 mL). The combined chloroform extract was washed with water (3 × 30 mL) and dried over anhydrous sodium sulfate. The solvent was removed under vacuum and the residue was recrystallized from benzene and hexane mixture to yield colorless to yellow granules with good yield 82-87%. 
2.3c (Z)
-2.4a (2Z)-ethyl 3,5-dihydro-7-methyl-2-(morpholino- methyl)-3-oxo-5-phenyl-2H-thiazolo [3,
2.5b 2-Dimethylaminomethylene-5-(3-methoxy-phenyl)-7-methyl-3-oxo-2,3-dihydro-5H-thiazolo[3,2-a]pyrimidine-6-carboxylic acid ethyl ester (5b):
General procedure for the synthesis of compounds 6a and 6b
A mixture of 2-dimethylaminomethylene-7-methyl-3-oxo-5-substituted phenyl-2,3-dihydro-5H -thiazolo [3,2−a]pyrimidine-6-carboxylic acid ethyl ester (5 mmol), 2-amino benzoic acid (5 mmol) and acetic acid (1 mL) in methanol (30 mL) was refluxed for 8 h (monitored by TLC). The excess methanol was removed under reduced pressure. The compound was diluted with water. The solid thus separated was filtered and dried to give yellow compound with 60-63% yield. 
2.6a 2-((1Z)-(6-(ethoxycarbonyl)-7-methyl-3-oxo-5-phenyl-3H-thiazolo[3,2-a]pyrimidin-2 (5H)-ylidene)methy lamino)benzoic acid (6a):
2.6b 2-(-(6-(ethoxycarbonyl)-5-(3-methoxyphenyl)-
7- methyl-3-oxo-3H-thiazolo[3,2-a]pyrimi -din-2(5H)-yli- dene)methylamino)benzoic acid (6b):
General procedure for the synthesis of compounds 7 (a-f)
To a solution of 5a/5b (5 mmol) in ethanol (30 mL) secondary amines like morpholine, piperidine and pyrrolidine (5 mmol) was added and then refluxed for several hours. Completion of the reaction was monitored by TLC. The solid separated was filtered and dried to get the desired product. [3,2-a] 
2.7a 7-Methyl-2-morpholin-4-ylmethylene-3-oxo-5-phenyl-2,3-dihydro-5H-thiazolo[3,2-a] pyrimidine-6-carboxylic acid ethyl ester (7a):
2.7b 5-(3-Methoxy-phenyl)-7-methyl-2-morpholin-4-ylmethylene-3-oxo-2,3-dihydro-5H-thia -zolo
Procedure for the synthesis of tricyclic thiazolopyrimidine
2.8a Procedure for the synthesis of ethyl 3-amino-2-cyano-5-(3-methoxyphenyl)-7-methyl-5H-thiazolo[3,2-a]pyrimidine-6-carboxylate (9):
To a warm solution of KOH (10 mmol) and pyrimidine derivative (8) (10 mmol) in ethanol (30 mL), bromomalononitrile (11 mmol) was added dropwise with constant stirring. The reaction mixture was stirred for 2 h. The solution was allowed to stand at room temperature for some time and the solid product precipitated. The precipitate was filtered and recrystallized from ethanol.
Yellow solid, yield 88%, M. 
2.8b Procedure for the synthesis 2-cyano-3-(1-ethoxyethylideneamino)-5-(3-methoxy-phenyl)-7-methyl-5H-thiazolo[3,2-a]pyrimidine-6-carboxylic acid ethyl ester (10):
A mixture of 9 (1.85 g, 5 mmol) and triethylorthoacetate (2 mL) was heated under reflux in acetic anhydride for 6 h, excess triethylorthoacetate and acetic anhydride was removed. 
Thiazolo[3,2-a]pyrimidines
2.8c Procedure for the synthesis 7-amino-8-imino-4-(3-methoxy-phenyl)-2,6-dimethyl-7,8-dihydro-4H-9-thia-1,4a,5,7-tetraaza-fluorene-3-carboxylic acid ethyl ester (11):
A mixture of 10 (2.2 g, 5 mmol) and hydrazine hydrate (7 mL) was stirred at room temperature for 2 h and then diluted with ethanol (20 mL 
X-ray diffraction analysis
Good quality single crystals of compounds 3, 5b and 7a were obtained by slow evaporation of ethanol. The X-ray diffraction data, for the compounds 3, 5b and 7a were collected on a Bruker Smart CCD Area Detector System using MoKα (0.71073 Å) radiation. The data were reduced using SAINT-Plus. 15 The structure was solved by Direct methods using SHELXS97 16 and refined by difference Fourier syntheses using SHELXL97. 16 The positions and anisotropic displacement parameters of all non-hydrogen atoms were included in the full-matrix least-square refinement using SHELXL97
16 and the refinement procedures were carried out until convergence was reached.
The H atoms were placed at calculated positions in the riding model approximation, their temperature factors were set to 1.2 times those of the equivalent isotropic temperature factors of the parent atoms. All other non-H atoms were refined anisotropically. Molecular diagrams were generated using ORTEP. 17 The mean plane calculation was done using the program PARST. 18 
Anti-microbial activity
Anti-microbial activities of the synthesized compounds 2d, 4a, 5a, 5b, 6a, 7a, 7d, 9 and 10 were screened against the two standard bacterial strains Staphylococcus aureus, E.coli and two standard fungal strains Aspergillus niger, Penicillium chrysogenum by Agar diffusion method with 3 different concentrations (0.5, 1.0, 2.0 mg/mL). 19, 20 For anti-bacterial activity test, media used was peptone 10 g, NaCl 10 g and yeast extract 5 g, agar 20 g in 1000 mL distilled water. Initially, the stock cultures of bacteria were revived by inoculating in broth media and grown at 37
• C for 18 h. The agar plates of the above media were prepared and wells were made in the plate. Each plate was inoculated with 18 h old cultures (100 μL, 10 −4 CFU) and spread evenly on the plate. After 20 min, the wells were filled with compound at different concentrations. The control wells with Gentamycin were also prepared. All the plates were incubated at 37
• C for 24 h and the diameter of inhibition zone were noted. inoculated with 48 h old cultures (100 μL, 10 4 CFU) and spread evenly on the plate. After 20 min, the wells were filled with different concentrations of samples. The control wells were filled with antibiotic. All the plates were incubated at 27
• C for 72 h and the diameter of inhibition zone were noted. The results of the anti-microbial activities are shown in table 3.
Result and Discussion
Chemistry
Compounds were synthesized by following procedure depicted in the schemes 1, 2, 3 and 4. The starting materials 7-methyl-3-oxo-5-(substituted phenyl)-2,3-dihydro-5H -thiazolo [ 
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ethyl esters 1(a-e) were prepared by treating 6-methyl-4-(substituted phenyl)-2-thioxo-1,2,3,4-tetrahydro-pyrimidine-5-carboxylic acid ethyl esters with chloro acetic acidin dioxane under reflux condition. These active methylene compounds 1a, 1d and 1e were further allowed to react with substituted aromatic aldehydes in presence of ammonium acetate to givearylidene derivatives of thiazolopyrimidine. The 1 H NMR spectra of compounds 2(a-d) indicate the absence of signals for the CH 2 proton around δ 3.7-3.9 ppm and additional signals in the aromatic region. Acid hydrolysis of arylidene derivative 2a leads to the formation of thiazolid-2,4-one (3) via the rupture of endocyclic C=N bond in pyrimidine ring by method 1. The hydrolyzed component (3) was also obtained by an alternative method 2, which involves in situ condensation followed by hydrolysis (scheme 1).
Compounds 1a and 1b undergo Mannich reaction with different secondary amines yielding compounds 4a and 4b. Further treatment of compounds 1(a-d) with dimethylformamide-dimethylacetal (DMF-DMA) under reflux condition gave 2-dimethylaminomethylene-7-methyl-3-oxo-5-(substituted phenyl)-2,3-dihydro-5H -thiazolo[3,2-a]pyrimidine-6-carboxylic acid ethyl esters 5 (a-d) . In order to confirm the spectral data, one of the derivative 5b was subjected to single crystal X-ray diffraction technique. Crystal structure of compound 5b showed that the product is Z-isomer. Treatment of compounds 5a and 5b with 2-amino benzoic acid gave the corresponding secondary amine derivative. Reaction of compounds 5a and 5b with secondary amines likes morpholine, piperidine or pyrrolidine taken in ethanol, on refluxing gave corresponding tertiaryamines 7 (a-f) (scheme 2). In addition to spectral technique, one of the tertiary amine was subjected to single crystal X-ray diffraction technique. Crystal structure of compound 7a showed the morpholine ring adopts chair conformation.
Compound 8 was synthesized from well-known Biginelli one pot cyclo-condensation reaction. 21 The reaction of dihydropyrimidine (8) with bromomalononitrile in presence of strong base resulted in the formation of compound 9. Product was confirmed by using spectral techniques. In the IR spectrum of compound 9 there is an appearance of sharp peak at 2189 cm 9 and triethylorthoacetate was refluxed in acetic anhydride to give compound 10. IR spectrum shows the absence of peaks around 3300-3150 cm −1 confirming the absence of -NH 2 group and from the 1 H NMR spectrum appearance of signals at δ 1.36, 1.45 and 4.28 ppm corresponds to additional -CH 3 ,-CH 3 and -CH 2 groups respectively. Further treatment of compound 10 with hydrazine hydrate in ethanol gave tricyclic thiazolopyrimidine 11. The ring system obtained was confirmed by IR spectrum. The absence of peak at 2189 cm −1 indicates that there is nonitrile group, the appearance of peak at 3361 and peaks at 3232 and 3190 cm −1 corresponds to -NH and -NH 2 group.
Crystallography
The details of crystal data and refinements are given in table 1 for the compounds 3, 5b and 7a. Tables  2a and 2b give respective hydrogen bond interactions. The ORTEP view of the molecule with atomic labeling (thermal ellipsoids drawn at 50% probability) of 3, 5b and 7a are shown in figures 1, 2a and 2b respectively. Figures 3a, 3b and 3c show the packing of molecules in the crystal structure.
Compounds 5b and 7a crystallize in the monoclinic space group containing one molecule each in the asymmetric unit. Both the compounds have almost similar substituents at C2, C3, C5, C6 and C7. In compounds 5b and 7a, the aryl ring at C5 is positioned axially to the pyrimidine ring 22 with a dihedral angle of 89.88(8) and 89.66 (8) • respectively. Aryl ring in both the compounds is projecting away from the plane of the thiazolopyrimidine ring. The ethyl carboxylate group at C6 in compound 7a is planar with respect to the thiazolopyrimidine ring whereas in compound 5b it slightly deviates from the mean plane of thiazolopyrimidine with dihedral angle of 17.77 (8) • this may be attributed to the presence of bulky group at C5. The centralpyrimidine ring in compounds 5b and 7a adopt twist boat conformation 22 due to the deviation of C5 and N2 atom from the mean plane C6/C7/C9/N1 constituting ring by -0.295/-0.297(3)and -0.052/-0.066(3)Ǻ respectively. The two values separated by '/' correspond to two different compounds i.e. 5b and 7a. In compound 5b, dimethylaminomethylene group adopts Z configuration. The substituted morpholine ring at C17 of compound 7a adopts chair conformation with the atoms N3 and O4 displaced from the mean plane of the remaining ring atoms (C18/C19/C20/C21) by 0.6863 (2) and −0.5735 (2)Ǻ, respectively.
The crystal structure of the compound 5b is stabilized by C-H. ------------4 a  7  1 0  1 7  4  5  7  ------5 a  ------------5 b  ------------6 a  0  3  5  0  2  3  ------7 a  ------0  1  3  ---7 d  ------------9 - Note: "-" Not Active, "ND" -Not Determined. (table 2b) . Finally, supramolecular assembly is further consolidated by π−π stacking interactions between the thiazolopyrimidine rings. This interaction is not observed in the case of compound 5b.
D-H·
· · A D-H H· · · A D · · · A D -H · · · A C8-Symmetry code: (i) x, +y − 1, +z (ii) x, −y + 1/2, +z + 1/2 (iii) x, −y + 1/2, +z − 1/2 (iv) x, −y + 1/2, +z − 1/2 (v) x, 1/2 − y, z − 1/2- - - - - - - - - - - 1 0 - - - 0 2 5 - - - - - -
Anti-microbial evaluation
The anti-microbial screening was done using agar diffusion method using different strains of bacteria and fungi. The results with the test compounds 2d, 4a, 5a, 5b, 6a, 7a, 7d, 9 and 10 reveal that only few compounds exhibit antimicrobial activity. Gentamicin and Amphotericin were used as reference to evaluate the potency of tested compounds. Compounds 6a, 7a and 10 showed moderate anti-microbial activity, while compound 4a showed very good activity even at low concentration. Compounds 2d, 5a, 5b, 7d and 9 did not show any activity against the tested microorganisms. The result of anti-microbial activity is tabulated in table 3.
Conclusion
This work reports the synthesis of a new series of thiazolopyrimidines. We have developed a new and convenient synthetic method for the preparation of arylidene derivatives of thiazolopyrimidine. During our studies with thiazolopyrimidines, we have also noticed that hydrolysis of arylidene derivative of thiazolopyrimidine via rupture of endocyclic C=N bonds in pyrimidine ring under acidic condition gives the same product as that obtained by in situ condensation followed by hydrolysis (scheme 1, method 1), for which a mechanism has been proposed. The structures of the products were confirmed by spectral techniques. In addition, crystal structures of two of the derivatives that yielded good quality crystals were verified by single crystal X-ray diffraction. Crystal structures reveal that compounds 5b and 7a are Z-isomers. Crystal structure of compound 7a showed the substituted morpholine ring adopts chair conformation. In both the derivatives, the ester at C6 adopts cis configuration with respect to C6-C7 double bond, which is a prerequisite for the molecule to exhibit calcium channel modulatory activity. 23 On screening all the compounds, only compounds 4a, 6a, 7a, 9 and 10 exhibited good anti-microbial activities at very low concentration of 0.5-2.0 mg/mL against Aspergillus niger, Penicillium chrysogenum, Staphylococcus aureus and Escherichia coli. using Gentamicin and Amphotericin as standards.
Supplementary Information
The CIF files are deposited at the Cambridge Crystallographic Data Centre. The deposition number of compounds 3, 5b and 7a are CCDC-966410, CCDC-975896 and CCDC-975899, respectively.
